Journal of Controlled Release 2019

3 papers
In 2019, the Journal of Controlled Release featured research focused on drug delivery systems for inflammatory diseases and oncology. Studies explored the use of inflammation-targeted nanoparticles to deliver combinations of all-trans-retinal and triptolide for treating conditions such as collagen-induced arthritis. Another area of investigation involved the development of polymeric micelles designed for chemo-immunotherapy, specifically targeting both tumor cells and tumor-associated macrophages to influence therapeutic outcomes. Research also addressed the optimization of drug-device combinations. One study examined paclitaxel-coated balloons, utilizing predictive models for coating dissolution kinetics and tissue retention to refine dosing dynamics. Prolific contributors during this period included researchers such as Lintao Cai, Ping Li, and Xin Chen. These works reflect a trend toward precision medicine through the integration of targeted nanocarriers and the mathematical modeling of drug release profiles.

Top Authors

AuthorPapers
Ping Li1

Papers

Title
Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy
Synergistic effect of all-trans-retinal and triptolide encapsulated in an inflammation-targeted nanoparticle on collagen-induced arthritis in mice
Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics